Literature DB >> 7900112

[Alpha-mannosidosis].

D Malm1, O K Tollersrud, L Tranebjaerg, J E Månsson.   

Abstract

Alpha-mannosidosis is a rare autosomal recessively inherited lysosomal storage disorder. We describe three patients with alpha-mannosidosis who were born in Tromsø between 1983 and 1987, in order to increase awareness of the disease. It is characterized by a typical facial look, with a prominent forehead, hypertelorism, small nose, flat nasal bridge and hypoplastic teeth. The patients are mentally retarded, often have dysostosis multiplex, recurrent infections and typically severe loss of hearing and delayed speech development. The disease is slowly progressive in the first decade, but shows considerable clinical variability. In most cases, the lymphocytes are vacuolized, but diagnosis depends on measurement of alpha-mannosidase activity in the lymphocytes. Prenatal diagnosis is available, based on chorionic villi sampling in the 9th to 11th week of pregnancy. No causal therapy is known, but establishment of the diagnosis is important to avoid complications, recognize hearing loss and provide speech therapy and special education. The specific diagnosis is critical for genetic counselling and prenatal diagnosis. The authors therefore outline the diagnostic strategy.

Entities:  

Mesh:

Year:  1995        PMID: 7900112

Source DB:  PubMed          Journal:  Tidsskr Nor Laegeforen        ISSN: 0029-2001


  6 in total

1.  Cognitive profile and activities of daily living: 35 patients with alpha-mannosidosis.

Authors:  L Borgwardt; A M Thuesen; K J Olsen; J Fogh; C I Dali; A M Lund
Journal:  J Inherit Metab Dis       Date:  2015-05-28       Impact factor: 4.982

2.  Mutations in the alpha 1,2-mannosidase gene, MAN1B1, cause autosomal-recessive intellectual disability.

Authors:  Muhammad Arshad Rafiq; Andreas W Kuss; Lucia Puettmann; Abdul Noor; Annapoorani Ramiah; Ghazanfar Ali; Hao Hu; Nadir Ali Kerio; Yong Xiang; Masoud Garshasbi; Muzammil Ahmad Khan; Gisele E Ishak; Rosanna Weksberg; Reinhard Ullmann; Andreas Tzschach; Kimia Kahrizi; Khalid Mahmood; Farooq Naeem; Muhammad Ayub; Kelley W Moremen; John B Vincent; Hans Hilger Ropers; Muhammad Ansar; Hossein Najmabadi
Journal:  Am J Hum Genet       Date:  2011-07-15       Impact factor: 11.025

3.  Enzyme replacement therapy for alpha-mannosidosis: 12 months follow-up of a single centre, randomised, multiple dose study.

Authors:  L Borgwardt; C I Dali; J Fogh; J E Månsson; K J Olsen; H C Beck; K G Nielsen; L H Nielsen; S O E Olsen; H M F Riise Stensland; O Nilssen; F Wibrand; A M Thuesen; T Pearl; U Haugsted; P Saftig; J Blanz; S A Jones; A Tylki-Szymanska; N Guffon-Fouiloux; M Beck; A M Lund
Journal:  J Inherit Metab Dis       Date:  2013-03-14       Impact factor: 4.982

4.  Spectrum of mutations in alpha-mannosidosis.

Authors:  T Berg; H M Riise; G M Hansen; D Malm; L Tranebjaerg; O K Tollersrud; O Nilssen
Journal:  Am J Hum Genet       Date:  1999-01       Impact factor: 11.025

5.  Alpha-mannosidosis: correlation between phenotype, genotype and mutant MAN2B1 subcellular localisation.

Authors:  Line Borgwardt; Hilde Monica Frostad Riise Stensland; Klaus Juul Olsen; Flemming Wibrand; Helle Bagterp Klenow; Michael Beck; Yasmina Amraoui; Laila Arash; Jens Fogh; Øivind Nilssen; Christine I Dali; Allan Meldgaard Lund
Journal:  Orphanet J Rare Dis       Date:  2015-06-06       Impact factor: 4.123

Review 6.  Alpha-mannosidosis.

Authors:  Dag Malm; Øivind Nilssen
Journal:  Orphanet J Rare Dis       Date:  2008-07-23       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.